Verastem Inc.

Last updated September 27, 2026

Organization details

Legal name
Verastem Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
VSTM
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001526119

Board of directors

Chief executives

Dan Paterson · President and CEO
Dates unknown

Board connections

6 of this board's directors also sit on 11 other boards.

Network of Verastem Inc.'s board connections Adicet Bio Inc. Adicet Bio Inc. Axogen Inc. Axogen Inc. Biogen Inc. Biogen Inc. Bone Biologics Corp Bone Biologics Corp Fortress Biotech Inc. Fortress Biotech Inc. Harvard Bioscience Inc. Harvard Bioscience Inc... Kyntra Bio Inc. Kyntra Bio Inc. Nurix Therapeutics Inc. Nurix Therapeutics Inc... Puma Biotechnology Inc Puma Biotechnology Inc Purple Biotech Ltd. Purple Biotech Ltd. Xeris Biopharma Holdings Inc. Xeris Biopharma Holdin... Anil Kapur Anil Kapur Brian M. Stuglik Brian M. Stuglik Eric K. Rowinsky Eric K. Rowinsky John Johnson John Johnson Michael Kauffman Michael Kauffman Robert E. Gagnon Robert E. Gagnon Verastem Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$787,837
32 sales by 6 insiders
Date Insider Transaction Shares Price Value
Sep 21, 2026 Calkins Daniel Officer (Chief Financial Officer) Open-market sale −55 $7.70 $424
Aug 3, 2026 Dan Paterson Director, Officer (President and CEO) Open-market sale −1,302 $5.81 $7,565
Jun 22, 2026 Dan Paterson Director, Officer (President and CEO) Open-market sale −20,871 $4.18 $87,241
Jun 22, 2026 Calkins Daniel Officer (Chief Financial Officer) Open-market sale −4,032 $4.18 $16,854
Jun 22, 2026 Calkins Daniel Officer (Chief Financial Officer) Open-market sale −57 $4.13 $235
May 21, 2026 Michael P. Bailey Director Grant or award +108,000 — —
May 21, 2026 Karin Anna Tollefson Director Grant or award +36,000 — —
May 21, 2026 Brian M. Stuglik Director Grant or award +36,000 — —
May 21, 2026 Eric K. Rowinsky Director Grant or award +36,000 — —
May 21, 2026 Michelle Robertson Director Grant or award +36,000 — —
May 21, 2026 Anil Kapur Director Grant or award +36,000 — —
May 21, 2026 Paul A. Bunn Director Grant or award +36,000 — —
May 21, 2026 John Johnson Director Grant or award +36,000 — —
May 4, 2026 Dan Paterson Director, Officer (President and CEO) Open-market sale −806 $5.82 $4,691
Mar 20, 2026 Calkins Daniel Officer (Chief Financial Officer) Grant or award −57 $5.74 $327

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.